Jacobio Pharmaceuticals Group Dividende
Dividende contrôle des critères 0/6
Jacobio Pharmaceuticals Group does not have a record of paying a dividend.
Informations clés
n/a
Rendement du dividende
-7.2%
Rendement des rachats
| Rendement total pour l'actionnaire | -7.2% |
| Rendement futur des dividendes | 0% |
| Croissance des dividendes | n/a |
| Prochaine date de paiement du dividende | n/a |
| Date ex-dividende | n/a |
| Dividende par action | n/a |
| Ratio de distribution | n/a |
Mises à jour récentes des dividendes
Pas de mise à jour
Recent updates
Most Shareholders Will Probably Agree With Jacobio Pharmaceuticals Group Co., Ltd.'s (HKG:1167) CEO Compensation
May 31
Is Jacobio Pharmaceuticals Group (HKG:1167) Using Debt Sensibly?
May 29We're Hopeful That Jacobio Pharmaceuticals Group (HKG:1167) Will Use Its Cash Wisely
May 10Time To Worry? Analysts Are Downgrading Their Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Outlook
Aug 26We're Not Very Worried About Jacobio Pharmaceuticals Group's (HKG:1167) Cash Burn Rate
Jul 29We Think Jacobio Pharmaceuticals Group (HKG:1167) Can Afford To Drive Business Growth
Apr 29What Percentage Of Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Shares Do Insiders Own?
Mar 21Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: Insufficient data to determine if 1167's dividends per share have been stable in the past.
Dividende croissant: Insufficient data to determine if 1167's dividend payments have been increasing.
Rendement des dividendes par rapport au marché
| Jacobio Pharmaceuticals Group Rendement des dividendes par rapport au marché |
|---|
| Segment | Rendement du dividende |
|---|---|
| Entreprise (1167) | n/a |
| 25% du marché (HK) | 3.2% |
| 25% du marché (HK) | 7.9% |
| Moyenne du secteur (Biotechs) | 1.1% |
| Analyste prévisionnel (1167) (jusqu'à 3 ans) | 0% |
Dividende notable: Unable to evaluate 1167's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Dividende élevé: Unable to evaluate 1167's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Bénéfice distribué aux actionnaires
Couverture des revenus: Insufficient data to calculate 1167's payout ratio to determine if its dividend payments are covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: Unable to calculate sustainability of dividends as 1167 has not reported any payouts.